Fresenius Kabi

Rediff.com » News » Fresenius Kabi

News for Fresenius Kabi

Business

Big blow: India revokes GSK cancer drug patent

India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that......

Stocks of MNCs with high promoter stake lose steam

Stock investors are turning averse to one of the most popular investment themes on Dalal Street in the past year or so. The recent rally in the shares of multinational companies (MNCs) with......

India Inc springs into action to pare promoter stakes

A slew of companies are rushing to sell their stakes over the next few weeks before the holiday season in Western countries start mid-December. Over half a dozen companies, including Hindustan......

All pharma M&As to be cleared by CCI: Plan panel group

A Planning Commission expert groupon Tuesdayrecommended that all mergers and acquisitions (M&As) in the pharmaceutical industry should be cleared by competition watchdog, CCI to ensure that such......

AstraZeneca India to delist scrip

AstraZeneca Pharma India, the Indian subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, has decided to delist its scrip from the Bombay Stock Exchange, National Stock Exchange and Bangalore......

Rediff News

Fresenius Kabi

News for Fresenius Kabi

Big blow: India revokes GSK cancer drug patent

Stocks of MNCs with high promoter stake lose steam

India Inc springs into action to pare promoter stakes

All pharma M&As to be cleared by CCI: Plan panel group

AstraZeneca India to delist scrip

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS